Search
for
Sort by
Research 511–540 of 1000+
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Tofacitinib therapy for children with severe alopecia areata
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Dermatologic Adverse Events from Cancer Treatments
- Current and future pharmacotherapy for alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report